EssilorLuxottica has announced the creation of its first Scientific Advisory Committee, bringing together five global leaders in science, medicine, and ethics. The initiative aims to strengthen the Group’s scientific foundation and guide its research strategy toward emerging frontiers in health and technology.
Why is EssilorLuxottica launching a scientific committee now?
As optics, AI, ethics, and life sciences increasingly converge, EssilorLuxottica is structuring its long-term vision with input from top experts. The committee will provide strategic and forward-looking insights into fields such as ophthalmology, oculomics, audiology, physics, optics, and bioethics. It will act as a catalyst for global scientific dialogue and exploration.
Who are the members of the Scientific Advisory Committee?
The committee includes five internationally renowned figures: Alain Aspect (2022 Nobel Prize in Physics), Alessio Figalli (2018 Fields Medal), Sharon Kujawa (audiology expert at Harvard), José-Alain Sahel (Chair of Ophthalmology at the University of Pittsburgh, 2024 Wolf Prize), and Effy Vayena (Professor of Bioethics at ETH Zurich). Their fields span basic science, medical innovation, and the ethical dimensions of technology.
What role will this committee play in the Group’s strategy?
It will serve as a strategic think tank, supporting EssilorLuxottica’s research efforts and identifying new areas for scientific exploration. The committee will also help foster relationships with leading academic institutions, ensuring that the Group’s innovations remain ethically responsible and scientifically grounded.
How does this initiative fit into EssilorLuxottica’s broader vision?
The Group builds on decades of innovation in optics, vision care, and wearable technologies. Launching the committee signals a commitment to deep scientific engagement and global leadership across health, perception, and smart interface technologies.
Will this committee influence future product innovations?
Yes, indirectly. By helping define scientific priorities, the committee will guide innovation in areas like embedded AI, personalized healthcare, and immersive digital experiences. It will also support ethical foresight as new technologies evolve.
EssilorLuxottica global Scientific Advisory Committee : Why is this initiative important right now?
Because it marks a strategic shift: EssilorLuxottica is no longer just innovating through products — it's building a global scientific vision to shape the future of health tech.
